Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.

C.B. Moelans; A.H.J. Maes; P.J. van Diest

Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.

Translated title of the contribution: Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.

C.B. Moelans, A.H.J. Maes, P.J. van Diest

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
Original language	Undefined/Unknown
Pages (from-to)	222-231
Number of pages	10
Journal	Journal of Pathology
Volume	225
Issue number	2
Publication status	Published - 2011

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/21710692

Cite this

@article{434d3698d4954f92a078c82ff9ec7cb3,

title = "Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.",

author = "C.B. Moelans and A.H.J. Maes and {van Diest}, P.J.",

year = "2011",

language = "Undefined/Unknown",

volume = "225",

pages = "222--231",

journal = "Journal of Pathology",

issn = "0022-3417",

publisher = "John Wiley & Sons Inc.",

number = "2",

}